Several lines of evidence have demonstrated that the NADPH oxidases (including NOX2 and NOX4) are directly enhanced by the hyperglycemia in diabetic heart [11–14], indicating that ROS derived from NADPH oxidase might contribute to diabetic myocardial damage. This evidence concerns the gene FMO5 and Hyperglycemia.